Hepatocellular carcinoma patients serum modulates the regenerative capacities of adipose mesenchymal stromal cells
Hepatocellular carcinoma (HCC) is one of the most prevalent cancers causing the highest mortality rate worldwide. Treatment options of surgery, radiation, cytotoxic drugs and liver transplantation suffer significant side effects and a high frequency of relapse. Stem cell therapy has been proposed as...
Main Authors: | Radwa Ayman Salah, Azza M. El-Derby, Zaynab El-Gammal, Bishoy Wadie, Sara M. Ahmed, Shimaa E. Elshenawy, Shireen Magdy, Ayman Salah, Mahmoud Gabr, Ihab Mohamed, Nagwa El-Badri |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-02-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024008259 |
Similar Items
-
Dysregulated MicroRNA Fingerprints and Methylation Patterns in Hepatocellular Carcinoma, Cancer Stem Cells, and Mesenchymal Stem Cells
by: Mohamed A. Nasr, et al.
Published: (2019-10-01) -
Long Noncoding RNA (lncRNA) MT1JP Suppresses Hepatocellular Carcinoma (HCC) in vitro
by: Mo W, et al.
Published: (2020-09-01) -
Analysis of HBV Genomes Integrated into the Genomes of Human Hepatoma PLC/PRF/5 Cells by HBV Sequence Capture-Based Next-Generation Sequencing
by: Tomotaka Ishii, et al.
Published: (2020-06-01) -
Liraglutide Exerts Protective Effects by Downregulation of <i>PPARγ</i>, <i>ACSL1</i> and <i>SREBP-1c</i> in Huh7 Cell Culture Models of Non-Alcoholic Steatosis and Drug-Induced Steatosis
by: Tea Omanovic Kolaric, et al.
Published: (2022-08-01) -
Cancer cell-soluble factors reprogram mesenchymal stromal cells to slow cycling, chemoresistant cells with a more stem-like state
by: Ahmed El-Badawy, et al.
Published: (2017-11-01)